Jun Aoki

Jun Aoki

Auto-generated profile, based on publicly available information

Jun Aoki

Department of Coloproctological Surgery, Juntendo University Faculty of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2015 in Diagnostic and Therapeutic Endoscopy
Verified
Journal Article
Open access
PDF file
YTYuichi Tomiki
Yuichi Tomiki
SOSeigo Ono
Seigo Ono
JAJun Aoki
Jun Aoki
RTRina Takahashi
Rina Takahashi
SIShun Ishiyama
Shun Ishiyama
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
Objective. A new sclerosing agent for hemorrhoids, aluminum potassium sulfate and tannic acid (ALTA), is attracting attention as a curative treatment for internal hemorrhoids without resection. The outcome and safety of ALTA sclerotherapy using an endoscope were investigated in the present study. Materials and Methods. Subjects comprised 83 internal hemorrhoid patients (61 males and 22 females). An endoscope was inserted and retroflexed in the rectum, and a 1st-step injection was applied to the upper parts of the hemorrhoids. The retroflexed scope was returned to the normal position, and 2nd–4th-step injections were applied to the middle and lower parts of the hemorrhoids under direct vision. The effects of endoscopic ALTA sclerotherapy were determined by evaluating the condition of the hemorrhoids using an anoscope and interviewing the patient 28 days after the treatment. Results. A cure, improvement, and failure were observed in 54 (65.1%), 27 (32.5%), and 2 (2.4%) patients, respectively, treated with ALTA. Complications developed in 4 patients (mild fever in 3 and hematuria in 1). Recurrence occurred in 9.6%. Conclusions. The results of the present study suggest that endoscopic ALTA has the potential to become a useful and minimally invasive approach for ALTA sclerotherapy.

1 January 2013 in Journal of Computer Assisted Tomography
Verified
Journal Article
Closed access
NKNatsumi Katsumata
Natsumi Katsumata
JAJun Aoki
Jun Aoki
MTMasahiko Tashiro
Masahiko Tashiro
ATAyako Taketomi-Takahashi
Ayako Taketomi-Takahashi
YTYoshito Tsushima
Yoshito Tsushima
Purpose The objective of this study was to characterize cervical computed tomography (CT) findings in Kawasaki disease (KD) patients that may facilitate early diagnosis. Methods We retrospectively reviewed cervical CT images of 78 children with cervical lymphadenopathy to analyze the distribution and morphology of lymphadenopathy and other soft-tissue findings. Results Twenty-eight patients were diagnosed with KD. Fifty had other diseases (non-KD). Retropharyngeal edema was observed in 82% (23/28) of KD and 30% (15/50) of non-KD (P < 0.01) cases. Retropharyngeal lymphadenopathy was observed in 89% (25/28) of KD and 48% (24/50) of non-KD (P < 0.01) cases. Levels III and IV lymphadenopathy was found in only 1 KD case, whereas levels III and IV lymphadenopathy was found in 58% (29/50) (P < 0.01) and 36% (18/50) (P < 0.01) of non-KD cases, respectively. Conclusions Retropharyngeal lymphadenopathy and retropharyngeal edema are relatively common features of KD on CT. Given the potentially serious complications of KD, this diagnosis is an important consideration in a young child presenting with these imaging findings.

31 December 2001 in Seminars in Musculoskeletal Radiology
Verified
Journal Article
Closed access
PDF file
JAJun Aoki
Jun Aoki
TITomio Inoue
Tomio Inoue
KTKatsumi Tomiyoshi
Katsumi Tomiyoshi
TSTetsuya Shinozaki
Tetsuya Shinozaki
HWHideomi Watanabe
Hideomi Watanabe
KEKeigo Endo
Keigo Endo
Positron emission tomography (PET) has become a very useful adjunct to anatomic imaging techniques, because it can provide an in vivo method for quantifying functional metabolism in normal and diseased tissues. Clinical trials with [18F] 2-deoxy-2-fluoro-D-glucose (FDG), the most commonly used radiolabeled tracer for PET imaging, has demonstrated increased accumulation of FDG in cancer tissue. FDG-PET is now widely used for the detection, differentiation, grading, staging, and monitoring of various neoplasms. However, the significance of FDG-PET in such evaluations of primary bone tumors and tumor-like lesions has not been extensively elucidated. In this article, we present recent advances in FDG-PET studies for evaluating primary bone tumors and tumor-like lesions.

20 January 2014 in Endoscopy
Verified
Journal Article
Closed access
PDF file
YTYuichi Tomiki
Yuichi Tomiki
SOSeigo Ono
Seigo Ono
JAJun Aoki
Jun Aoki
RTRina Takahashi
Rina Takahashi
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
Sclerotherapy with injection of aluminum potassium sulfate and tannic acid (ALTA) has been reported to be a new, valid treatment method for internal hemorrhoids that does not involve resection [1] [2]. With this method, ALTA is injected into the submucosa at the base of hemorrhoids by performing direct four-step injection (involving the upper, deep middle, shallow middle, and lower parts of the hemorrhoids) using an anoscope. We considered the possibility of using endoscopic injection instead of an anoscope in ALTA sclerotherapy. Anesthesia was not induced in the periphery of the anus. A transparent hood was attached to the tip of the scope. As the first step, the scope was inserted and retroflexed in the rectum to inject 2 mL ALTA into the upper parts of the target swollen internal hemorrhoid ([Fig. 1]). Subsequently, after the scope was placed in a normal position, ALTA was injected into the deep middle, shallow middle, and lower parts as the second, third, and fourth steps, respectively ([Fig. 2]). After ALTA had been injected into all internal hemorrhoids, the endoscope was removed and the injected sites were massaged with the index finger to promote the diffusion of ALTA throughout the rectal area, to prevent the formation of rectal ulcers by local stagnation of the ALTA solution in the hemorrhoids. The merits of using endoscopy in ALTA sclerotherapy include: not requiring anesthesia; preventing the injection needle from entering layers deeper than the submucosa; and enabling therapists to confirm that the drug has been appropriately injected into the submucosa with a monitor. While acute, thrombosed, strangulated, and external hemorrhoids should not be treated using ALTA, the use of endoscopy, rather than anoscopy, in the direct four-step injection procedure in ALTA sclerotherapy may bring additional benefit for treating internal hemorrhoids, since the endoscopic procedure provides safer and more accurate ALTA injection. Endoscopy_UCTN_Code_TTT_1AS_2AZ

16 December 2019 in Disease Markers
Verified
Journal Article
Open access
PDF file
RTRina Takahashi
Rina Takahashi
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
KSKiichi Sugimoto
Kiichi Sugimoto
SMShunsuke Motegi
Shunsuke Motegi
RTRyoichi Tsukamoto
Ryoichi Tsukamoto
JMJoe Matsuoka
Joe Matsuoka
Objective. We examined serum anti-p53 antibodies (S-p53Ab) in colorectal cancer. Specifically, we retrospectively investigated the use of S-p53Ab as a prognostic marker after surgery for colorectal cancer. Materials and Methods. The levels of S-p53Ab, carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9) were measured in 160 colorectal cancer patients who underwent surgical treatment. The rate of postoperative change (RPC) in the S-p53Ab titer was calculated as [subsequent antibody titer-lowest titer]/lowest titer. Results. A relationship between recurrence and RPC in the S-p53Ab titer was not observed in patients who tested negative for S-p53Ab preoperatively. In addition, no patients, who tested negative for S-p53Ab preoperatively, tested positive for S-p53Ab at the follow-up after surgery. Of the patients who tested positive for S-p53Ab preoperatively, those recurrences had a significantly higher RPC compared with those who did not (p<0.001). Conclusions. Although S-p53Ab is not a significant tumor marker in patients who test negative preoperatively, increases in the S-p53Ab titer should be continuously monitored and measured in patients who are positive for this antibody preoperatively, regardless of whether they later test negative.

1 January 2016 in Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Verified
Journal Article
Open access
PDF file
KHKumpei Honjo
Kumpei Honjo
RTRyoichi Tsukamoto
Ryoichi Tsukamoto
JAJun Aoki
Jun Aoki
RTRina Takahashi
Rina Takahashi
SMShinya Munakata
Shinya Munakata
KSKazuhiro Sakamoto
Kazuhiro Sakamoto
症例は60歳台,男性.検診で貧血を指摘され,大腸内視鏡検査でS状結腸癌と診断され,紹介受診となった.腹部所見で右下腹部から側腹部に拡がる30cm大の巨大な腫瘤を認めた.腹部CT検査で,右鼠径部から側腹部に小腸の脱出がみられ,右鼠径ヘルニアと診断した. また,右鼠径部に精巣が同定され,右停留精巣と診断した.以上より,S状結腸癌に対するS状結腸切除術と同時に右鼠径ヘルニア修復術,右精巣摘出術を施行した.腹腔鏡所見では右外鼠径ヘルニアで,小腸がヘルニア門から脱出していた.まず,小腸の還納を試みたが癒着が強く還納不能であり,開腹移行し癒着剝離を行った.続いて,前方アプローチによるLichtenstein法で鼠径ヘルニアを修復し,精巣摘出術も行った.その後S状結腸切除術を施行した.自験例では停留精巣を伴っていたため,精索が陰囊まで続かず,右下腹部から側腹部の皮下までヘルニア囊が拡がったと考えられた.